{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T23:17:56Z","timestamp":1783207076048,"version":"3.54.6"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T00:00:00Z","timestamp":1452816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.eplepsyres.2016.01.002","type":"journal-article","created":{"date-parts":[[2016,1,12]],"date-time":"2016-01-12T15:04:11Z","timestamp":1452611051000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Long-term safety and seizure outcome in Japanese patients with Lennox\u2013Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial"],"prefix":"10.1016","volume":"121","author":[{"given":"Yoko","family":"Ohtsuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harumi","family":"Yoshinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiyoshi","family":"Shirasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumiko","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Iyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1474-4422(08)70292-8","article-title":"Lennox\u2013Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology","volume":"8","author":"Arzimanoglou","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0010","series-title":"Epileptic Syndromes in Infancy, Childhood and Adolescence","first-page":"89","article-title":"The Lennox\u2013Gastaut syndrome","author":"Beaumanoir","year":"1985"},{"issue":"Suppl. 9","key":"10.1016\/j.eplepsyres.2016.01.002_bib0015","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1111\/j.1528-1167.2007.01402.x","article-title":"Weight issues for people with epilepsy \u2013 a review","volume":"48","author":"Ben-Menachem","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0020","first-page":"909","article-title":"Long term follow-up in patients with Lennox\u2013Gastaut syndrome. Epileptological aspects, psychomotor development and social adaptation","volume":"80","author":"Blatter-Arifi","year":"1991","journal-title":"Schweiz. Rundsch. Med. Prax."},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.eplepsyres.2014.01.011","article-title":"In vitro transport assays of rufinamide, pregabalin, and zonisamide by human P-glycoprotein","volume":"108","author":"Chan","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures","volume":"22","author":"Commission on Classification and Terminology of the International League Against Epilepsy","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0035","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ejpn.2014.05.008","article-title":"Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines","volume":"18","author":"Coppola","year":"2009","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0040","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.seizure.2010.09.008","article-title":"Rufinamide in children and adults with Lennox\u2013Gastaut syndrome: first Italian multicenter experience","volume":"19","author":"Coppola","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0045","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1017\/S0012162206000843","article-title":"Aggravation of epilepsy by anti-epileptic drugs","volume":"48","author":"Gayatri","year":"2006","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0050","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1021\/cb500108p","article-title":"Nav1,1 modulation by a novel triazole compound attenuates epileptic seizures in rodents","volume":"9","author":"Gilchrist","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0055","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/01.wnl.0000303813.95800.0d","article-title":"Rufinamide for generalized seizures associated with Lennox\u2013Gastaut syndrome","volume":"70","author":"Glauser","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0060","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1111\/apa.12587","article-title":"Updated Japanese growth references for infants and preschool children, based on historical, ethnic and environmental characteristics","volume":"103","author":"Kato","year":"2014","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eplepsyres.2015.02.003","article-title":"Retention rates of rufinamide in pediatric epilepsy patients with and without Lennox\u2013Gastaut syndrome","volume":"112","author":"Kessler","year":"2015","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.14581\/jer.12009","article-title":"The efficacy and tolerability of rufinamide in intractable pediatric epilepsy","volume":"2","author":"Kim","year":"2012","journal-title":"J. Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1600-0404.2010.01334.x","article-title":"Adjunctive rufinamide in Lennox\u2013Gastaut syndrome: a long-term, open-label extension study","volume":"122","author":"Kluger","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0080","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.yebeh.2010.01.005","article-title":"First European long-term experience with the orphan drug rufinamide in childhood-onset refractory epilepsy","volume":"17","author":"Kluger","year":"2010","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0085","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0883073814532545","article-title":"Role of P-glycoprotein in refractoriness of seizures to antiepileptic drugs in Lennox\u2013Gastaut syndrome","volume":"30","author":"Kumar","year":"2014","journal-title":"J. Child Neurol."},{"issue":"Suppl. 6","key":"10.1016\/j.eplepsyres.2016.01.002_bib0090","first-page":"S375","article-title":"The influence of rufinamide on sodium currents and action potential firing in rodent neurons","volume":"46","author":"McLean","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0095","unstructured":"Ministry of Education, Culture, Sports, Science and Technology (MEXT), 2012. Statistical Abstract 2012 edition 3 Physical Education and Sports. Physical Development of Students http:\/\/www.mext.go.jp\/component\/english\/__icsFiles\/afieldfile\/2013\/08\/13\/1302985_05.pdf (Male) http:\/\/www.mext.go.jp\/component\/english\/__icsFiles\/afieldfile\/2013\/08\/13\/1302985_06.pdf (Female) (accessed 25.06.15)."},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0100","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1136\/bmj.e281","article-title":"Diagnosis and management of the epilepsies in adults and children: summary of updated NICE guidance","volume":"344","author":"Nunes","year":"2012","journal-title":"Br Med J"},{"issue":"Suppl. 3","key":"10.1016\/j.eplepsyres.2016.01.002_bib0105","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1528-1157.1996.tb01820.x","article-title":"Long-term prognosis of Lennox\u2013Gastaut syndrome","volume":"37","author":"Oguni","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0110","first-page":"257","article-title":"Long-term prognosis of the Lennox\u2013Gastaut syndrome","volume":"44","author":"Ohtsuka","year":"1990","journal-title":"Jpn. J. Psychiatry Neurol."},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0115","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.eplepsyres.2014.08.019","article-title":"Rufinamide as an adjunctive therapy for Lennox\u2013Gastaut syndrome: a randomized double-blind placebo-controlled trial in Japan","volume":"108","author":"Ohtsuka","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0120","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1476-5381.2009.00191.x","article-title":"Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives","volume":"159","author":"Shah","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0125","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/epi.12689","article-title":"Safety and retention rate of rufinamide in 300 patients: a single pediatric epilepsy center experience","volume":"55","author":"Thome-Souza","year":"2014","journal-title":"Epilepsia"},{"issue":"Suppl. 3","key":"10.1016\/j.eplepsyres.2016.01.002_bib0130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1528-1157.1996.tb01821.x","article-title":"Evolution of Lennox\u2013Gastaut syndrome: a long-term longitudinal study","volume":"37","author":"Yagi","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.01.002_bib0135","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.addr.2011.12.003","article-title":"The transport of antiepileptic drugs by P-glycoprotein","volume":"64","author":"Zhang","year":"2012","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092012111630002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092012111630002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:34:30Z","timestamp":1760276070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092012111630002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":27,"alternative-id":["S092012111630002X"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.01.002","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term safety and seizure outcome in Japanese patients with Lennox\u2013Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}